2.07
前日終値:
$2.11
開ける:
$2.12
24時間の取引高:
322.47K
Relative Volume:
0.10
時価総額:
$55.03M
収益:
$155.00K
当期純損益:
$-30.01M
株価収益率:
-1.2395
EPS:
-1.67
ネットキャッシュフロー:
$-11.98M
1週間 パフォーマンス:
+4.02%
1か月 パフォーマンス:
+1.97%
6か月 パフォーマンス:
-73.50%
1年 パフォーマンス:
-61.60%
Inmune Bio Inc Stock (INMB) Company Profile
名前
Inmune Bio Inc
セクター
電話
(858) 964-3720
住所
225 NE MIZNER BLVD, SUITE 640, BOCA RATON, CA
INMB を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
INMB
Inmune Bio Inc
|
2.07 | 56.09M | 155.00K | -30.01M | -11.98M | -1.67 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Inmune Bio Inc Stock (INMB) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-07-01 | ダウングレード | BTIG Research | Buy → Neutral |
2025-07-01 | ダウングレード | Scotiabank | Sector Outperform → Sector Underperform |
2025-01-28 | 開始されました | Rodman & Renshaw | Buy |
2024-10-21 | 開始されました | Alliance Global Partners | Buy |
2024-09-27 | 開始されました | Raymond James | Outperform |
2024-08-22 | 開始されました | Scotiabank | Sector Outperform |
2023-06-01 | 開始されました | Robert W. Baird | Outperform |
2022-05-24 | ダウングレード | B. Riley Securities | Buy → Neutral |
2021-07-07 | 繰り返されました | Maxim Group | Buy |
2021-04-21 | 開始されました | B. Riley Securities | Buy |
2021-01-22 | 繰り返されました | Maxim Group | Buy |
2020-09-01 | 開始されました | BTIG Research | Buy |
2020-07-15 | 繰り返されました | H.C. Wainwright | Buy |
すべてを表示
Inmune Bio Inc (INMB) 最新ニュース
Inmune Bio Submits Manuscript on Alzheimer’s Trial - TipRanks
INmune Bio submits manuscript on Phase 2 Alzheimer’s trial results - Investing.com
Inmune Bio announces submission of phase 2 mindful trial results in Alzheimer's - MarketScreener
INmune Bio submits manuscript on Phase 2 Alzheimer’s trial results By Investing.com - Investing.com Australia
INmune Bio Announces Submission of Phase 2 MINDFuL Trial Results in Alzheimer’s Disease to npj Dementia, a Nature Portfolio Journal - Stock Titan
Predicting INmune Bio Inc. trend using moving averagesJuly 2025 Recap & Free Daily Entry Point Trade Alerts - newser.com
Analyzing INmune Bio Inc. with risk reward ratio chartsJobs Report & Growth Focused Investment Plans - newser.com
Using RSI to spot recovery in INmune Bio Inc.Market Rally & Weekly Market Pulse Updates - newser.com
INmune Bio Inc Stock Analysis and ForecastCandlestick Trading Patterns & Free Real-Time Trading Alerts Every Day - earlytimes.in
What analysts say about INmune Bio Inc stockTechnical Breakout Signals & Free Daily Stock Hotspot Analysis - Early Times
AI Stocks: Whats the profit margin of INmune Bio IncJuly 2025 Retail & Community Consensus Stock Picks - خودرو بانک
Analysis Recap: Is INmune Bio Inc. forming a double bottomEarnings Summary Report & Fast Moving Market Watchlists - خودرو بانک
INmune Bio, Inc. (NASDAQ:INMB) Short Interest Update - MarketBeat
Aug Macro: Whats the profit margin of INmune Bio IncEarnings Risk Summary & High Accuracy Trade Alerts - khodrobank.com
How does Battalion Oil Corporation compare to its peersWeekly Investment Report & AI Enhanced Trading Signals - khodrobank.com
INmune Bio, Inc. (NASDAQ:INMB) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Risk Analysis: Can INmune Bio Inc stock outperform in a bear marketJuly 2025 Sector Moves & Daily Volume Surge Trade Alerts - خودرو بانک
Will INmune Bio Inc outperform the market in YEAR2025 Biggest Moves & Weekly Stock Performance Updates - خودرو بانک
Block Trades: What are INmune Bio Incs earnings expectationsQuarterly Growth Report & Safe Entry Zone Identification - khodrobank.com
Has INmune Bio Inc. formed a bullish divergenceJuly 2025 Closing Moves & Daily Profit Maximizing Trade Tips - newser.com
Retail Surge: Is INmune Bio Inc a stock for growth or value investorsQuarterly Investment Review & AI Driven Stock Reports - خودرو بانک
Aug Macro: Is INmune Bio Inc. impacted by rising rates2025 Geopolitical Influence & AI Based Trade Execution Alerts - خودرو بانک
INmune Bio, Inc. (NASDAQ:INMB) Receives $18.40 Consensus PT from Analysts - Defense World
Loss Report: Can INmune Bio Inc stock outperform in a bear marketWeekly Profit Analysis & Scalable Portfolio Growth Methods - خودرو بانک
VIX Spike: Is INmune Bio Inc stock undervalued right nowJuly 2025 Rallies & Reliable Trade Execution Plans - خودرو بانک
Meme Stocks: How is i 80 Gold Corp managing supply chain issuesEarnings Summary Report & Daily Chart Pattern Signal Reports - خودرو بانک
Aug Summary: Will INmune Bio Inc benefit from geopolitical trendsJuly 2025 EndofMonth & Capital Efficient Trade Techniques - خودرو بانک
Aug Outlook: Is INmune Bio Inc a stock for growth or value investorsJuly 2025 Chart Watch & Accurate Intraday Trade Tips - khodrobank.com
Breakout Move: Can INmune Bio Inc expand into new marketsInsider Buying & Risk Adjusted Buy/Sell Alerts - خودرو بانک
Bearish Setup: Is INmune Bio Inc stock a value trapNew Guidance & Weekly Breakout Opportunity Watchlist - خودرو بانک
Risks Report: Is INmune Bio Inc. stock a falling knife or bargain buyWeekly Investment Summary & Accurate Entry and Exit Point Alerts - خودرو بانک
Published on: 2025-09-16 12:20:17 - خودرو بانک
Aug Macro: Will INmune Bio Inc. benefit from rate cutsJuly 2025 Update & Consistent Profit Trade Alerts - خودرو بانک
Will INmune Bio Inc benefit from geopolitical trendsWeekly Loss Report & Consistent Growth Stock Picks - خودرو بانک
Aug Retail: Will INmune Bio Inc. outperform the market in YEAR2025 Support & Resistance & High Accuracy Investment Signals - خودرو بانک
INmune Bio (INMB) Completes Pilot Manufacturing of CORDStrom for Skin Disorder - GuruFocus
Aug Drivers: Can INmune Bio Inc. stock outperform in a bear marketShare Buyback & Target Return Focused Picks - خودرو بانک
INmune Bio Announces Successful Completion of First Commercial Pilot-Scale Manufacturing Run of CORDStrom™ at CGT Catapult - The Manila Times
INmune Bio Inc. Achieves Key Milestone with Successful Pilot Manufacturing Run of CORDStrom™ for RDEB Treatment - Quiver Quantitative
Breakthrough in Rare Disease Treatment: INmune Bio Successfully Manufactures RDEB Cell Therapy at UK Facility - Stock Titan
Gains Recap: What are INmune Bio Incs earnings expectations2025 Winners & Losers & Community Verified Trade Alerts - خودرو بانک
Aug Update: Can INmune Bio Inc. expand into new marketsJuly 2025 Reactions & Smart Allocation Stock Tips - خودرو بانک
How to escape a deep drawdown in INmune Bio Inc.2025 Market Outlook & Verified Momentum Stock Alerts - newser.com
Recovery Setup Building in INmune Bio Inc. Experts Say2025 Macro Impact & Real-Time Stock Price Movement Reports - beatles.ru
INmune Bio (INMB) Loses 23.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
Is INmune Bio Inc. stock a value trapJuly 2025 Highlights & Weekly Breakout Watchlists - beatles.ru
INmune Bio Inc. stock trend forecastJuly 2025 Fed Impact & Long-Term Safe Investment Ideas - Newser
Technical signs of recovery in INmune Bio Inc.Quarterly Profit Summary & High Accuracy Investment Entry Signals - Newser
What is INmune Bio Inc.’s book value per shareJuly 2025 Drop Watch & AI Based Trade Execution Alerts - خودرو بانک
Does INmune Bio Inc. have a competitive edge2025 Geopolitical Influence & Fast Moving Stock Watchlists - خودرو بانک
Is INmune Bio Inc. stock a falling knife or bargain buyJuly 2025 Closing Moves & Verified Short-Term Plans - خودرو بانک
Inmune Bio Inc (INMB) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):